Skip to Main Content

Advertisement

Skip Nav Destination

OnlineFirst

CCR Translations December 8 2023
To Quiesce or Senesce, that is the question for Dedifferentiated Liposarcoma
Clin Cancer Res (2023)
Research Article December 7 2023
Circulating tumor DNA enables sensitive detection of actionable gene fusions and rearrangements across cancer types
Clin Cancer Res (2023)
Research Article December 7 2023
PD-1 Expression on Intratumoral Regulatory T Cells is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear Cell Renal Cell Carcinoma Patients
Clin Cancer Res (2023)
Research Article December 7 2023
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results
Clin Cancer Res (2023)
Research Article December 7 2023
Molecular and pathological characterization of YAP1-expressing small cell lung cancer cell lines leads to reclassification as SMARCA4-deficient malignancies
Clin Cancer Res (2023)
Research Article December 7 2023
Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma
Clin Cancer Res (2023)
Clinical Trials: Immunotherapy December 7 2023
Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
Clin Cancer Res (2023)
Translational Cancer Mechanisms and Therapy December 7 2023
PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis
Clin Cancer Res (2023)
Translational Cancer Mechanisms and Therapy December 7 2023
Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade
Clin Cancer Res (2023)
Precision Medicine and Imaging December 7 2023
Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma
Clin Cancer Res (2023)
CCR Drug Updates December 7 2023
FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation
Clin Cancer Res (2023)
Clinical Trials: Targeted Therapy December 7 2023
SAR-096: Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)
Clin Cancer Res (2023)
Precision Medicine and Imaging December 7 2023
Biomarkers of Pathologic Complete Response to Neoadjuvant Immunotherapy in Mismatch Repair–Deficient Colorectal Cancer
Clin Cancer Res (2023)
Clinical Trials: Targeted Therapy December 7 2023
A Phase I Study of the CDK4/6 Inhibitor Palbociclib in Combination with Cetuximab and Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
Clin Cancer Res (2023)
CCR Translations December 7 2023
The Dance Between Tumor Molecular Biology and Antitumor Immune Response
Clin Cancer Res (2023)
CCR Translations December 7 2023
Methodical Manipulation of the TME in Ovarian Cancer
Clin Cancer Res (2023)
CCR Translations December 6 2023
Overcoming Resistance in Chronic Lymphocytic Leukemia – Maybe Less is More?
Clin Cancer Res (2023)
Research Article December 5 2023
Phase I/II study of the WEE1 inhibitor adavosertib (AZD1775) in combination with carboplatin in children with advanced malignancies: Arm C of the AcSé-ESMART trial
Clin Cancer Res (2023)
Clinical Trial Brief Report December 5 2023
A phase Ib study of the DNA-PK inhibitor peposertib combined with neoadjuvant chemoradiation in patients with locally advanced rectal cancer
Clin Cancer Res (2023)
Clinical Trials: Targeted Therapy December 4 2023
Pilot Study of High-Dose Pemetrexed in Patients with Progressive Chordoma
Clin Cancer Res (2023)
Translational Cancer Mechanisms and Therapy December 4 2023
Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In Vivo
Clin Cancer Res (2023)
Clinical Trials: Targeted Therapy December 4 2023
Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study
Clin Cancer Res (2023)
Precision Medicine and Imaging December 4 2023
Tumor Volume Growth Rates and Doubling Times during Active Surveillance of IDH-mutant Low-Grade Glioma
Clin Cancer Res (2023)
Precision Medicine and Imaging December 4 2023
Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
Clin Cancer Res (2023)
Research Briefs: Clinical Trial Brief Reports December 4 2023
A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia
Clin Cancer Res (2023)
CCR Translations December 4 2023
PRESSING Need of Precision Care in HER2-Positive Colorectal Cancer: The ELEPHANT in the Room
Clin Cancer Res (2023)
CCR Translations December 4 2023
Exploiting Iron Metabolism as a Therapeutic Vulnerability in Glioblastoma
Clin Cancer Res (2023)
Perspective December 1 2023
Backfilling Patients in Phase I Dose Escalation Trials Using Bayesian Optimal Interval Design (BOIN)
Clin Cancer Res (2023)
Research Briefs: Precision Medicine and Therapeutics December 1 2023
TROP2 is associated with primary resistance to immune checkpoint inhibition in patients with advanced non-small cell lung cancer
Clin Cancer Res (2023)
Clinical Trial Brief Report December 1 2023
Evaluation of the SSTR2-targeted radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as imaging biomarker in patients with intracranial meningioma
Clin Cancer Res (2023)
Research Article December 1 2023
Aneuploidy Landscape in Precursors of Ovarian Cancer
Clin Cancer Res (2023)
CCR Translations December 1 2023
New T-cell therapies for brain metastasis, CD133 in the driver’s seat
Clin Cancer Res (2023)
CCR Translations December 1 2023
Pancreatic Cancer’s PD1-roadblock: When T-cell reinvigoration is not enough
Clin Cancer Res (2023)
Research Article November 30 2023
Clinical and Immunologic Features of Germline Pathogenic Variant (gPV) Positive Patients with Melanoma
Clin Cancer Res (2023)
Research Article November 30 2023
Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 Studies
Clin Cancer Res (2023)
Review November 28 2023
Immunotherapy of MSI Cancer: Facts and Hopes
Clin Cancer Res (2023)
Clinical Trials: Targeted Therapy November 28 2023
Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma
Clin Cancer Res (2023)
Clinical Trials: Targeted Therapy November 28 2023
Overall Survival and Exploratory Biomarker Analyses of Abemaciclib plus Trastuzumab with or without Fulvestrant versus Trastuzumab plus Chemotherapy in HR+, HER2+ Metastatic Breast Cancer Patients
Clin Cancer Res (2023)
Precision Medicine and Imaging November 28 2023
PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial
Clin Cancer Res (2023)
Translational Cancer Mechanisms and Therapy November 28 2023
FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner
Clin Cancer Res (2023)
Precision Medicine and Imaging November 28 2023
Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
Clin Cancer Res (2023)
Translational Cancer Mechanisms and Therapy November 28 2023
Tumor-Infiltrating CD103+ Tissue-Resident Memory T Cells and CD103CD8+ T Cells in HNSCC Are Linked to Outcome in Primary but not Metastatic Disease
Clin Cancer Res (2023)
Translational Cancer Mechanisms and Therapy November 28 2023
Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer
Clin Cancer Res (2023)
Review November 28 2023
Facts and Hopes in Neoadjuvant Immunotherapy: Current Approvals and Emerging Evidence
Clin Cancer Res (2023)
Review November 28 2023
Translational Aspects of Epithelioid Sarcoma: Current Consensus
Clin Cancer Res (2023)
Review November 28 2023
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research
Clin Cancer Res (2023)
Research Article November 27 2023
Modulating gut microbiota prevents anastomotic leak to reduce local implantation and dissemination of colorectal cancer cells after surgery
Clin Cancer Res (2023)
Research Article November 22 2023
Development of resistance to type II JAK2 inhibitors in MPN depends on AXL kinase and is targetable
Clin Cancer Res (2023)
Research Article November 22 2023
A Phase I/II Study of GSK525762 Combined With Fulvestrant in Patients With Hormone Receptor-Positive/HER2-Negative (HR+/HER2−) Advanced or Metastatic Breast Cancer
Clin Cancer Res (2023)
Precision Medicine and Imaging November 21 2023
Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors
Clin Cancer Res (2023)
Page 1 of 3
Close Modal

or Create an Account

Close Modal
Close Modal